ABSTRACT Lipid microspheres have been used as carriers of drugs such as prostaglandin E, (lipo PGE1) and corticosteroid (liposteroid). Lipo-PGE, is used for the treatment of chronic arterial occlu sive diseases because its activity is far greater than that of free PGE, in vivo. To verify the fact that the drug carriers, lipid microspheres, are preferentially taken up by endothelial cells, we labeled lipid microspheres with a fluorescent probe, DiI (DiI-LM), and observed them in some in vitro models. Stoichiometric fluorescence was obtainable, and the fluorescence was stable between pH 3.3 and pH 8.9. Human umbilical vein endothelial cells and cells of a human endothelial cell line, ECV304, showed increased uptake of DiI-LM, 81% and 61%, respectively. In contrast, uptakes were less than 7% in hu man skin fibroblasts, 3T3 cells, and human neutrophils. Prominent perinuclear fluorescence was also observed in endothelial cells by fluorescence microscopy. DiI-LM and flow cytometric analysis will be useful for studies to elucidate the precise mechanism of the selective accumulation of lipid microspheres by cells in blood vessel walls.
The use of liposomes as a drug-delivery system has many advantages, e.g., augmented effectiveness and re duced toxicity of the incorporated drugs (1) . However, liposomes are relatively unstable; i.e., they are easily denatured within weeks after preparation, and they are not easily mass-produced (2) .
Lipid microspheres (Intralipid, Intralipos, etc.) are stable substances and are in widespread use for parenteral nutrition in patients. They average 0.2-0.3 ,um in diameter and consist of two main components: soybean oil as a core and lecithin as a surfactant (3) . Recently, corticosteroid and prostaglandin E, (PGE I), both of which have soybean-oil-soluble properties, have been incorporated into lipid microspheres (2) (3) (4) . To act efficiently in blood vessel walls, the drug carriers of the incorporated drugs must be preferentially incorpo rated by the endothelial cells. The selective accumula tion of lipid microspheres in endothelial cells has not yet been fully studied, especially in models in vitro.
1,1'-Dioctadecyl-3, 3 , 3' , 3'-tetramethylindocarbocyanine perchlorate, DiI, is a lipophilic fluorescent probe (5) .
It is used for labeling such lipoproteins as low-density lipoprotein (LDL) and acetylated LDL (5, 6) . Once the Dil-labeled lipoprotein is taken up by the cell and de graded by lysosomes, it accumulates in the lysosomal membranes (6) . DiI accumulated in the cells is visible with a fluorescent microscope and can be easily quan tified by flow cytometry (6) (7) (8) . Because of these prop erties, DiI probes should prove especially useful for studying the mechanisms whereby lipid microspheres are incorporated into endothelial cells.
Utilizing DiI probes, the purpose of the present study was to determine if human endothelial cells preferen tially take up lipid microspheres.
MATERIALS AND METHODS

Preparation of the DiI probe
The solubility of DiI in soybean oil was determined by adding graded quantities of DiI (MW 936; Molecular Probes, Inc., Eugene, OR) to purified soybean oil at 4°C, 25°C and 40°C. The mixture was then stirred, sonicated for 1 hr, and visually examined for precipi tate. At concentrations higher than 1 mg/g, there was a precipitate of DiI (especially at the lower tempera tures), but at 1 mg/g, DiI appeared to be fully soluble at all 3 temperatures. Therefore, a concentration of 1 mg/g was used in the preparation of the Dil-labeled probe.
Preparation of lipid emulsions (DiI-LM and LM) (3) DiI (20 mg) was dissolved in 20 g of purified soybean oil containing 2.4 g of purified yolk lecithin. The mix ture was poured into 175 ml of 2.58% glycerol aqueous solution while being agitated by bubbling with N2 gas. Subsequently, the mixture was emulsified with a Manton-Gaulin homogenizer until no particles larger than 1 ,u m in diameter were detectable with the light microscope. The concentration of the labeled lipid emulsion was expressed as weight of Dil/volume of lipid emulsion. One milliliter of the final product con tained 100 mg of purified soybean oil and 0.1 mg of DiI. The particle sizes of DiI-LM averaged 0.27,um in diameter, as measured by an Autosizer IIc (Malvern Instruments, Malvern, UK), and the pH of the lipid emulsion was 4.79. The emulsion was stored at 4°C until use. A soybean oil emulsion without DiI was pre pared in the same way as described above, except that DiI was not added to the soybean oil. The concentra tion of LM was expressed as the weight of soybean oil/volume of lipid emulsion.
Spectroscopy of DiI-LM
The spectra of 3 samples (0.2,ug/ml of DiI-LM, 0.2 ,ug/ml of DiI in ethanol, and a blank lipid emulsion containing 200,ug of soybean oil/ml) were examined with a fluorospectrophotometer (RF-520, Shimadzu, Kyoto). The excitation wavelength was fixed at 488 nm, and the emission wavelength was scanned from 488 nm to 570 nm. The relationship between the concentration of DiI LM and the fluorescence intensity was examined at an excitation wavelength of 488 nm and an emission wave of 570 nm.
The effect of pH on the fluorescence intensity of D11 LM was examined by adding 0.5 N HC1 or 0.5 N NaOH and reading the results at the same settings (A ex = 488 nm, Aem = 570 nm).
Preparation of adherent cells and neutrophils
Human umbilical vein endothelial cells (HUVEC) were collected by modification of Jaffe's method (9) and cultured in M199 medium (Gibco, Grand Island, NY) supplemented with 20% fetal calf serum (FCS, Gibco), 100 U/ml penicillin, 100,ug/ml streptomycin, and 10 ng/ml human recombinant basic fibroblast growth factor (10) (Progen Biotechnik GmbH, Heidel berg, FRG) in 6-well, flat bottom plates (Costar, Cam bridge, MA) coated with 10,ug/ml bovine fibronectin (Mitsubishi Chemical Industries, Tokyo) at 37°C under an atmosphere containing 5% CO2. Only cells in the second passage were used in the flow cytometric study.
ECV304, an endothelial cell line derived from the umbilical vein of a healthy donor, was established by Takahashi et al. (11) . ECV304 cells (5 X 104/ml) were plated in medium A: M199 supplemented with 10% FCS, 100 U/ml penicillin, and 100 ,ug/ml streptomycin (Gibco) in Petri dishes (60-mm diameter, Miles, Naper ville, IL) in 6-well, flat bottom plates.
Human fibroblasts were derived from skin biopsies of healthy donors. The 3T3 cells (12) were obtained from the American Type Culture Collection. The human fibroblasts and the 3T3 cells were both cultured in Dul becco's Modified Eagle's Medium (Gibco) containing 10% fetal calf serum, 100 U/ml penicillin, and 100 ,ug/ml streptomycin (Gibco) in 6-well plates. The hu man fibroblasts were used when they were between the fifth and ninth passages.
In labeling cells for flow cytometry, the 4 adherent cells were washed three times with PBS after reaching confluency, and then the medium was replaced with a serum-free medium, ASF-301 (13) (Ajinomoto, Tokyo).
Neutrophils were separated from heparinized periph eral blood by PolymorphprepTM (Nycomed Pharma, Oslo, Norway) density gradient centrifugation. Col lected cells were washed and then bathed in trisammo nium chloride solution for 5 -10 min at room tempera ture to lyse red blood cells. Neutrophils were dispersed in a 12 X 75 mm round bottom tube (Falcon #2054, Becton Dickinson, Lincoln Park, NJ) containing SFM 101 medium (14) (Nissui, Tokyo) at a concentration of 1 X 106 cells/ml.
Fluorescence microscopy
For fluorescence microscopy, cells were grown on glass coverslips. The cells were incubated with 1 ug/ml DiI-LM at 37°C in ASF-301 for 4 hr. The cells were then washed four times with Dulbecco's modified phosphate-buffered saline (PBS; Flow Labs, Irvine, UK) and fixed with 2% formaldehyde for 30 min. The coverslips were inverted over a drop of glycerol gelatin (GG-1, Sigma, St. Louis, MO) prior to viewing. Cells were examined with a microscope (Olympus IMT-2, Tokyo) equipped with a reflected-light fluorescence apparatus (IMT2-RFL, Olympus). DiI was visualized using the standard rhodamine excitation/emission filter combinations. Photomicrographs were taken with Kodak Tri-X film.
Evaluation of DiI-LM incorporation on flow cytometry
Adherent cells or neutrophils were incubated in ASF 301 or in SFM-101, respectively, generally for 4 hr with Dil-LM. Adherent cells were harvested by incubation with PBS containing 0.05% (w/v) EDTA-2Na (Wako, Osaka, Japan) after washing four times with PBS. Then, the suspended cells were washed three times with PBS containing 1% (w/v) of bovine serum albumin (Wako). Neutrophils were harvested by centrifugation and washed four times with PBS after the labeling pro cedure. After washing, the cells were fixed with 2% formaldehyde (Polysciences, Warrington, PA) in PBS and stored at 4°C in the dark until flow cytometric analysis.
DiI-LM labeled cells were analyzed on a Cytoron Absolute (Ortho Diagnostic Systems K.K., Tokyo) equipped with an argon laser operating at 488 nm (7, 8) . Forward angle and 90° light scatter gates were established to exclude dead cells and cell debris from the analyses. Fluorescence (>570 nm) signals from the accumulated DiI in cells were collected by a red photo multiplier, converted to a digital format, and processed for storage and display in one-parameter log scale fre quency histograms. In the neutrophil experiment, re sidual lymphocytes were detected by flow cytometric gating procedures and not counted. Five thousand cells were analyzed for each sample. Autofluorescence of unlabeled cells on flow cytometric analysis were used as negative controls in each experiment. The cut-off fluorescence intensity was set so that 99% of the con trol cell autofluorescence was negative (15) . The per centage of positive cells was expressed by counting only the labeled Dil-laden cells that exceeded the cut-off value.
Evaluation of LM or DiI-LM incorporation by measur ing the amount of triacylglycerol in cells ECV304 cells were incubated in ASF-301 with LM or DiI-LM for 4 hr. After incubation, cells were washed five times with PBS and then sonicated. The amounts of triacylglycerol and protein in the cell lysate were measured by an enzymatic triacylglycerol assay kit (De terminer TG-S 555, Kyowa Medex, Tokyo) and protein assay kit (Bio-Rad Laboratories, Richmond, CA), re spectively.
Detection of liberated DiI from Di1-LM ECV304 cells were incubated in ASF-301 with DiI LM for 4 hr. The culture supernatants were collected by pipetting and applied to an ultrafiltration microtube (cut-off level: MW 5,000; Ultrafree CL-LCC, Nippon Millipore Ltd., Tokyo). After centrifugation at 15,000 rpm for 30 min, the fluorescence intensity of the ultra filtrated fluid was measured with a fluorospectropho tometer (Titertek Fluoroskan II, Flow Labs).
Cell count
The growth rate of ECV304 cells was assessed as fol lows: confluent cells were trypsinized and plated in 24 well plates (10,000 per well; Flow Labs, Mclean, VA) in 1 ml of medium A. The cells were trypsinized at 24 hour intervals up to 120 hr and counted using a particle counter (PC-607, Erma, Tokyo) (8).
Statistics
Statistical significance was accepted at the P = 0.05 level, calculated from Student's t-test.
RESULTS
With k ex fixed at 488 nm, prominent peaks were obtained at 572 nm in the spectra of DiI-LM and DiI dissolved in ethanol, respectively; there was no such peak in the spectrum of unlabeled lipid emulsion. The fluorescence of DiI-LM at the A ex of 488 nm and A em of 570 nm was augmented linearly (r = 0.997) in accordance with the concentration of DiI. The fluores cence of DiI-LM obtained under the same condition was little affected at any pH (between 3.3 and 8.9) of the lipid emulsion.
The effects of different concentrations of DiI-LM and LM on ECV304 cell growth are shown in Fig. 1 . In terms of cell counts throughout the 5 day culture period, cell cultures supplemented with DiI-LM at 10 ng/ml (10 mg of soybean oil/ml) or with blank lipid microspheres were indistinguishable from cultures con taining medium A alone. However, at the higher con centration of 100 ng/ml (100 ,u g of soybean oil/ml), both inhibited cell growth, LM after 2 and Dil-LM af ter 3 days of incubation. By day 5, cell counts averaged 11.6 ± 1.1 X 104/well in the control cultures (medium A alone), 4.9 ± 0.3 X 104/well in the cultures to which 10 ng/ml DiI was added, and 4.2 ± 0.5 X 104/well in the cultures to which LM containing 10 ,u g of soybean oil/ml was added; the differences are statistically sig nificant (P < 0.05). However there was no significant difference between the cell counts of the Dil-LM and LM cultures, indicating that cell proliferation was little affected by the presence of DiI.
To visualize the uptake of DiI-LM by cells, cultures were incubated with DiI-LM and examined by fluores cence microscopy. ECV304 cells were brightly stained with DiI, revealing a perinuclear distribution (Fig. 2B) . In contrast, human fibroblasts were little stained (Fig.  2D) .
To examine if the labeling procedure of LM with DiI affects its incorporation by cells, the amounts of triacylglycerol in cells incubated with LM or DiI-LM were measured. The triacylglycerol content in cells in cubated with unlabeled or labeled LM increased signifi cantly compared to that in control cells. However, there was no significant difference between the former 2 sets of conditions, indicating that the uptake of LM was little affected by the presence of DiI (Fig. 3A) . (Fig. 3B ).
Representative histograms of the 4 types of adherent cells (HUVEC, ECV304 cells, human fibroblasts and 3T3 cells) and that of neutrophils are shown in Fig. 4 . Cells were labeled with 500 ng/ml DiI-LM for 4 hr at 37°C. In the HUVEC, the labeled cells showed a mean fluorescence intensity (MFI) of 144.0 on an arbitrary channel, while the unlabeled cells showed an MFI of 44.1, which corresponds to 80.7% of the cells being positive (Fig. 4A) . In the ECV304 cells, the labeled cells showed an MFI of 119.9, while the unlabeled cells showed an MFI of 42.3; 60.6% of the cells were posi tive (Fig. 4B) . In contrast, for human fibroblasts, the labeled cells showed an MFI of 85.7, while the un labeled cells showed an MFI of 67.0; 1.6% of the cells were positive (Fig. 4C ). In the 3T3 cells, the labeled cells showed an MFI of 60.0, while the unlabeled cells showed an MFI of 31.1; 6.3% of the cells were positive (Fig. 4D) . In the neutrophils, the labeled cells showed an MFI of 39.5, while the unlabeled cells showed an MFI of 38.7; 0.3% of the cells were positive (Fig. 4E) .
The time-dependent and dose-dependent curves of uptake of DiI-LM by the 4 types of adherent cells and by neutrophils are shown in Fig. 5, A and B , respec tively. The uptake of this ligand by HUVEC increased prominently with dose or time. The uptake of DiI-LM by ECV304 cells reached saturation at 2 hr of incuba tion or at 1000 ng/ml. In contrast, human fibroblasts, 3T3 cells and neutrophils showed little uptake of this ligand.
A displacement assay was used to determine if un labeled lipid microspheres interfere with the uptake of DiI-LM by ECV304 cells. In cells incubated with 500 ug/ml Dil-LM for 4 hr, the proportion of positive cells was 61.0 ± 2.5%, and the number decreased moderate ly to the level of 24.4 ± 5.2% at 5 mg/ml of unlabeled LM (Fig. 6) . , with LM (column C) containing 1 mg/ml of soybean oil, respectively, or without any addition (column A) for 4 hr at 3TC. Column A shows that the triacylglycerol was undetectable using our assay system described in Materials and Methods (less than 5 ug/mg cell protein). The averages of S.D. of quadruplicate assays are shown. Panel B: Fluorescence intensity of the culture supernatants, before and after ultrafiltration. ECV304 cells were incubated with 500 ng/ml or 1000 ng/ml of DiI-LM in ASF-301 for 4 hr. The fluorescence intensity of culture supernatants sup plemented with 500 ng/ml or 1000 ng/ml Dil-LM or without any addition is shown in column A, C and E, respectively. The fluorescence intensity of ultrafiltrated fluids of culture super natants supplemented with 500 ng/ml or 1000 ng/ml DiI-LM is shown in column B and D, respectively. The conditions for ultra filtration with an ultrafiltration microtube were described in Materi als and Methods. The averages ± S.D. of quadruplicate assays are demonstrated. A.U. = arbitrary units.
DISCUSSION
Using an in vitro model, the present study revealed a striking difference among cell types in taking up labeled lipid microspheres. Two endothelial cells, HUVEC and ECV304, actively took up DiI-LM, whereas human fibroblasts, 3T3 cells and neutrophils did not.
Liposomes reach their "target" organ and/or cells either actively or by passive targeting. In active target ing, incorporation of liposomes by the target organs and/or cells is accelerated by modulating their surfaces with antibodies (16) or ligands (17) . In passive target (19) , the probes that are also used for labeling lipophilic membranes (e.g., DiI and 3,3'-dioctadecyloxacarbocyanine) (20) , and intracellular pH indicators (e.g., carboxyfluorescein and pyranine) (21, 22) . The fluorescence of DiI in this study was inde pendent of pH between pH 3.3 and pH 8.9, and the fluorescence in the cells was easily quantified by flow cytometry. The probe did not affect cell viabilities (Fig.  1) . The basic spectroscopic properties of Dil-LM were unchanged for at least one year after preparation (K. Suzuki et al., unpublished observation). We used two serum-free media to observe whether cells take up Dil-labeled lipid microspheres. ASF-301 medium (13) and SFM-101 (14) are mainly designed for culturing adherent cells and suspended cells, respective ly. The culture system is free from the effects of various substances such as lipoproteins, apolipoproteins and some proteins having opsonic effects. Therefore, the uptake by endothelial cells is independent of apolipo protein receptors such as those for apo B/E or apo E (23). This active incorporation was totally suppressed at 4°C (Fig. 5B ).
There were some differences in autofluorescence levels among the cells (Fig. 4, A to E) ; those of human fibroblasts tended to be higher than the levels observed in the other cells. Therefore, we used both dose-depend ent and time-dependent analyses in measuring the in corporation of Dil-LM by cells, comparing each to their own autofluorescence level with flow cytometry. This is assumed to be valid for detecting uptake by cells, but absolute values of amounts taken up by cells are not obtainable by the method used in this study.
The metabolism of lipid microspheres as described in other reports is not as simple as that observed in the in vitro model used in the present study. When the tri glyceride in the cores of some microspheres is hydro lyzed, surface phospholipids are left behind as vesicles (24) . These vesicles then scavenge tissue cholesterol and thereby become transporters of cholesterol to the liver (25) . Phospholipid vesicles or infused phospholipid liposomes have also been shown to acquire apolipopro teins in the circulation, including apo E, apo A-I, and possibly apo A-IV (26) . However, the aim of utilizing lipid microspheres as drug carriers should be realized when cells in the blood vessel walls take up some of the drug containing infused LM before the entire course of metabolism is completed in vivo. In fact, a substantial increase of LM uptake by HUVEC and ECV304 was observed within only 30 min (Fig. 5A) . If the lipid microspheres containing a drug fail to reach the blood vessel walls, the phospholipid residue from them at least will not accelerate arteriosclerosis. The volume of lipid emulsions containing steroid or PGE1 are both only 1 or 2 ml in clinical use now.
